Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro
Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro
复制标题
FK317对体内和体外多重耐药肿瘤的不同作用
DOI:
--
复制
发表时间:
1998
期刊:
影响因子:
--
通讯作者:
K. Shimomura
中科院分区:
文献类型:
--
作者:
Y. Naoe;M. Inami;Shoji Takagaki;S. Matsumoto;I. Kawamura;F. Nishigaki;S. Tsujimoto;T. Manda;K. Shimomura
FK317, a novel substituted dihydrobenzoxazine, was examined for antitumor effects on multidrug‐resistant (MDR) tumor cells in vitro and in vivo. In nude mice, FK317 markedly inhibited the growth of s.c. implanted KB‐V1 vinblastine (VLB)‐resistant human epidermal carcinoma KB cells, as well as the parent cells (KB‐3‐1). However, KB‐V1 showed much greater resistance to FK317 than to VLB and adriamycin (ADM) in the in vitro study. This resistance was reversed by the addition of verapamil, whereby intracellular accumulation of FK317 in the KB‐V1 cells was also decreased. After incubation of FK317 in human and mouse blood, it was shown to be rapidly metabolized to a monodeacetylated form, and slowly metabolized further to a dideacetylated form. With the removal of the acetyl groups from FK317, resistance indexes in KB‐V1 and SBC‐3/ADM, ADM‐resistant human lung carcinoma, decreased. In addition, photolabeling of P‐glycoprotein with [3H]azidopine in KB‐V1 plasma membrane was completely inhibited by FK317, but not by the deacetylated metabolites. These results indicate that FK317 is metabolized to deacetylated forms, which do not bind to P‐glycoprotein and are incorporated into MDR cells, causing cytotoxic effects.
登录
查看更多内容
影响因子:
3.6
作者:
J. Zamora;H. Pearce;W. T. Beck
通讯作者:
J. Zamora;H. Pearce;W. T. Beck
DOI:
10.1073/pnas.83.12.4538
发表时间:
1986-06-01
影响因子:
11.1
作者:
RONINSON, IB;CHIN, JE;PASTAN, I
通讯作者:
PASTAN, I
影响因子:
2.4
作者:
Safa,AR
通讯作者:
Safa,AR
影响因子:
3.9
作者:
Wortham, Matthew;Czerwinski, Maciej;Wan, Yu-Jui Yvonne
通讯作者:
Wan, Yu-Jui Yvonne
DOI:
--
发表时间:
1981
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Elbaum,D;Nagel,RL
通讯作者:
Nagel,RL